Cargando…
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021
We measured COVID-19 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection at primary care/outpatient level among adults ≥ 65 years old using a multicentre test-negative design in eight European countries. We included 592 SARS-CoV-2 cases and 4,372 test-negative controls in the main an...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299744/ https://www.ncbi.nlm.nih.gov/pubmed/34296676 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.29.2100670 |
| _version_ | 1783726327565647872 |
|---|---|
| author | Kissling, Esther Hooiveld, Mariette Sandonis Martín, Virginia Martínez-Baz, Iván William, Naoma Vilcu, Ana-Maria Mazagatos, Clara Domegan, Lisa de Lusignan, Simon Meijer, Adam Machado, Ausenda Brytting, Mia Casado, Itziar Murray, Josephine-L K. Belhillil, Sylvie Larrauri, Amparo O’Donnell, Joan Tsang, Ruby de Lange, Marit Rodrigues, Ana Paula Riess, Maximilian Castilla, Jesús Hamilton, Mark Falchi, Alessandra Pozo, Francisco Dunford, Linda Cogdale, Jade Jansen, Tessa Guiomar, Raquel Enkirch, Theresa Burgui, Cristina Sigerson, Debbie Blanchon, Thierry Martínez Ochoa, Eva María Connell, Jeff Ellis, Joanna van Gageldonk-Lafeber, Rianne Kislaya, Irina Rose, Angela MC Valenciano, Marta Andrews, Nick Lopez Bernal, Jamie Whitaker, Heather Guerrisi, Caroline Launay, Titouan Masse, Shirley van der Werf, Sylvie Enouf, Vincent Cuddihy, John McKenna, Adele Joyce, Michael de Gascun, Cillian Moran, Joanne Miqueleiz, Ana Navascués, Ana Trobajo-Sanmartín, Camino Ezpeleta, Carmen Moreno, Paula López Gorricho, Javier Ardanaz, Eva Baigorria, Fernando Barricarte, Aurelio de la Cruz, Enrique Egüés, Nerea García Cenoz, Manuel Guevara, Marcela Moreno-Iribas, Conchi Sayón, Carmen Gomez, Verónica Nunes, Baltazar Roquete, Rita Silva, Adriana Melo, Aryse Costa, Inês Verdasca, Nuno Conde, Patrícia Marques, Diogo FP Molesworth, Anna Quinn, Leanne Leyton, Miranda Campbell, Selin Thoulass, Janine McMenamin, Jim Mateo, Ana Martínez Basile, Luca Castrillejo, Daniel Quiñones Rubio, Carmen Delgado-Sanz, Concepción Oliva., Jesús |
| author_facet | Kissling, Esther Hooiveld, Mariette Sandonis Martín, Virginia Martínez-Baz, Iván William, Naoma Vilcu, Ana-Maria Mazagatos, Clara Domegan, Lisa de Lusignan, Simon Meijer, Adam Machado, Ausenda Brytting, Mia Casado, Itziar Murray, Josephine-L K. Belhillil, Sylvie Larrauri, Amparo O’Donnell, Joan Tsang, Ruby de Lange, Marit Rodrigues, Ana Paula Riess, Maximilian Castilla, Jesús Hamilton, Mark Falchi, Alessandra Pozo, Francisco Dunford, Linda Cogdale, Jade Jansen, Tessa Guiomar, Raquel Enkirch, Theresa Burgui, Cristina Sigerson, Debbie Blanchon, Thierry Martínez Ochoa, Eva María Connell, Jeff Ellis, Joanna van Gageldonk-Lafeber, Rianne Kislaya, Irina Rose, Angela MC Valenciano, Marta Andrews, Nick Lopez Bernal, Jamie Whitaker, Heather Guerrisi, Caroline Launay, Titouan Masse, Shirley van der Werf, Sylvie Enouf, Vincent Cuddihy, John McKenna, Adele Joyce, Michael de Gascun, Cillian Moran, Joanne Miqueleiz, Ana Navascués, Ana Trobajo-Sanmartín, Camino Ezpeleta, Carmen Moreno, Paula López Gorricho, Javier Ardanaz, Eva Baigorria, Fernando Barricarte, Aurelio de la Cruz, Enrique Egüés, Nerea García Cenoz, Manuel Guevara, Marcela Moreno-Iribas, Conchi Sayón, Carmen Gomez, Verónica Nunes, Baltazar Roquete, Rita Silva, Adriana Melo, Aryse Costa, Inês Verdasca, Nuno Conde, Patrícia Marques, Diogo FP Molesworth, Anna Quinn, Leanne Leyton, Miranda Campbell, Selin Thoulass, Janine McMenamin, Jim Mateo, Ana Martínez Basile, Luca Castrillejo, Daniel Quiñones Rubio, Carmen Delgado-Sanz, Concepción Oliva., Jesús |
| author_sort | Kissling, Esther |
| collection | PubMed |
| description | We measured COVID-19 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection at primary care/outpatient level among adults ≥ 65 years old using a multicentre test-negative design in eight European countries. We included 592 SARS-CoV-2 cases and 4,372 test-negative controls in the main analysis. The VE was 62% (95% CI: 45–74) for one dose only and 89% (95% CI: 79–94) for complete vaccination. COVID-19 vaccines provide good protection against COVID-19 presentation at primary care/outpatient level, particularly among fully vaccinated individuals. |
| format | Online Article Text |
| id | pubmed-8299744 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Centre for Disease Prevention and Control (ECDC) |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82997442021-08-02 Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021 Kissling, Esther Hooiveld, Mariette Sandonis Martín, Virginia Martínez-Baz, Iván William, Naoma Vilcu, Ana-Maria Mazagatos, Clara Domegan, Lisa de Lusignan, Simon Meijer, Adam Machado, Ausenda Brytting, Mia Casado, Itziar Murray, Josephine-L K. Belhillil, Sylvie Larrauri, Amparo O’Donnell, Joan Tsang, Ruby de Lange, Marit Rodrigues, Ana Paula Riess, Maximilian Castilla, Jesús Hamilton, Mark Falchi, Alessandra Pozo, Francisco Dunford, Linda Cogdale, Jade Jansen, Tessa Guiomar, Raquel Enkirch, Theresa Burgui, Cristina Sigerson, Debbie Blanchon, Thierry Martínez Ochoa, Eva María Connell, Jeff Ellis, Joanna van Gageldonk-Lafeber, Rianne Kislaya, Irina Rose, Angela MC Valenciano, Marta Andrews, Nick Lopez Bernal, Jamie Whitaker, Heather Guerrisi, Caroline Launay, Titouan Masse, Shirley van der Werf, Sylvie Enouf, Vincent Cuddihy, John McKenna, Adele Joyce, Michael de Gascun, Cillian Moran, Joanne Miqueleiz, Ana Navascués, Ana Trobajo-Sanmartín, Camino Ezpeleta, Carmen Moreno, Paula López Gorricho, Javier Ardanaz, Eva Baigorria, Fernando Barricarte, Aurelio de la Cruz, Enrique Egüés, Nerea García Cenoz, Manuel Guevara, Marcela Moreno-Iribas, Conchi Sayón, Carmen Gomez, Verónica Nunes, Baltazar Roquete, Rita Silva, Adriana Melo, Aryse Costa, Inês Verdasca, Nuno Conde, Patrícia Marques, Diogo FP Molesworth, Anna Quinn, Leanne Leyton, Miranda Campbell, Selin Thoulass, Janine McMenamin, Jim Mateo, Ana Martínez Basile, Luca Castrillejo, Daniel Quiñones Rubio, Carmen Delgado-Sanz, Concepción Oliva., Jesús Euro Surveill Rapid Communication We measured COVID-19 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection at primary care/outpatient level among adults ≥ 65 years old using a multicentre test-negative design in eight European countries. We included 592 SARS-CoV-2 cases and 4,372 test-negative controls in the main analysis. The VE was 62% (95% CI: 45–74) for one dose only and 89% (95% CI: 79–94) for complete vaccination. COVID-19 vaccines provide good protection against COVID-19 presentation at primary care/outpatient level, particularly among fully vaccinated individuals. European Centre for Disease Prevention and Control (ECDC) 2021-07-22 /pmc/articles/PMC8299744/ /pubmed/34296676 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.29.2100670 Text en This article is copyright of the authors or their affiliated institutions, 2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
| spellingShingle | Rapid Communication Kissling, Esther Hooiveld, Mariette Sandonis Martín, Virginia Martínez-Baz, Iván William, Naoma Vilcu, Ana-Maria Mazagatos, Clara Domegan, Lisa de Lusignan, Simon Meijer, Adam Machado, Ausenda Brytting, Mia Casado, Itziar Murray, Josephine-L K. Belhillil, Sylvie Larrauri, Amparo O’Donnell, Joan Tsang, Ruby de Lange, Marit Rodrigues, Ana Paula Riess, Maximilian Castilla, Jesús Hamilton, Mark Falchi, Alessandra Pozo, Francisco Dunford, Linda Cogdale, Jade Jansen, Tessa Guiomar, Raquel Enkirch, Theresa Burgui, Cristina Sigerson, Debbie Blanchon, Thierry Martínez Ochoa, Eva María Connell, Jeff Ellis, Joanna van Gageldonk-Lafeber, Rianne Kislaya, Irina Rose, Angela MC Valenciano, Marta Andrews, Nick Lopez Bernal, Jamie Whitaker, Heather Guerrisi, Caroline Launay, Titouan Masse, Shirley van der Werf, Sylvie Enouf, Vincent Cuddihy, John McKenna, Adele Joyce, Michael de Gascun, Cillian Moran, Joanne Miqueleiz, Ana Navascués, Ana Trobajo-Sanmartín, Camino Ezpeleta, Carmen Moreno, Paula López Gorricho, Javier Ardanaz, Eva Baigorria, Fernando Barricarte, Aurelio de la Cruz, Enrique Egüés, Nerea García Cenoz, Manuel Guevara, Marcela Moreno-Iribas, Conchi Sayón, Carmen Gomez, Verónica Nunes, Baltazar Roquete, Rita Silva, Adriana Melo, Aryse Costa, Inês Verdasca, Nuno Conde, Patrícia Marques, Diogo FP Molesworth, Anna Quinn, Leanne Leyton, Miranda Campbell, Selin Thoulass, Janine McMenamin, Jim Mateo, Ana Martínez Basile, Luca Castrillejo, Daniel Quiñones Rubio, Carmen Delgado-Sanz, Concepción Oliva., Jesús Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021 |
| title | Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021 |
| title_full | Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021 |
| title_fullStr | Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021 |
| title_full_unstemmed | Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021 |
| title_short | Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021 |
| title_sort | vaccine effectiveness against symptomatic sars-cov-2 infection in adults aged 65 years and older in primary care: i-move-covid-19 project, europe, december 2020 to may 2021 |
| topic | Rapid Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299744/ https://www.ncbi.nlm.nih.gov/pubmed/34296676 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.29.2100670 |
| work_keys_str_mv | AT kisslingesther vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT hooiveldmariette vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT sandonismartinvirginia vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT martinezbazivan vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT williamnaoma vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT vilcuanamaria vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT mazagatosclara vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT domeganlisa vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT delusignansimon vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT meijeradam vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT machadoausenda vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT bryttingmia vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT casadoitziar vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT murrayjosephinelk vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT belhillilsylvie vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT larrauriamparo vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT odonnelljoan vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT tsangruby vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT delangemarit vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT rodriguesanapaula vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT riessmaximilian vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT castillajesus vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT hamiltonmark vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT falchialessandra vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT pozofrancisco vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT dunfordlinda vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT cogdalejade vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT jansentessa vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT guiomarraquel vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT enkirchtheresa vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT burguicristina vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT sigersondebbie vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT blanchonthierry vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT martinezochoaevamaria vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT connelljeff vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT ellisjoanna vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT vangageldonklafeberrianne vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT kislayairina vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT roseangelamc vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT valencianomarta vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT andrewsnick vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT lopezbernaljamie vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT whitakerheather vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT guerrisicaroline vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT launaytitouan vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT masseshirley vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT vanderwerfsylvie vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT enoufvincent vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT cuddihyjohn vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT mckennaadele vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT joycemichael vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT degascuncillian vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT moranjoanne vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT miqueleizana vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT navascuesana vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT trobajosanmartincamino vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT ezpeletacarmen vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT morenopaulalopez vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT gorrichojavier vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT ardanazeva vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT baigorriafernando vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT barricarteaurelio vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT delacruzenrique vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT eguesnerea vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT garciacenozmanuel vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT guevaramarcela vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT morenoiribasconchi vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT sayoncarmen vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT gomezveronica vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT nunesbaltazar vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT roqueterita vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT silvaadriana vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT meloaryse vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT costaines vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT verdascanuno vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT condepatricia vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT marquesdiogofp vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT molesworthanna vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT quinnleanne vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT leytonmiranda vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT campbellselin vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT thoulassjanine vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT mcmenaminjim vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT mateoanamartinez vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT basileluca vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT castrillejodaniel vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT quinonesrubiocarmen vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT delgadosanzconcepcion vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 AT olivajesus vaccineeffectivenessagainstsymptomaticsarscov2infectioninadultsaged65yearsandolderinprimarycareimovecovid19projecteuropedecember2020tomay2021 |